We have reaffirmed our Neutral recommendation on PetMed Express (NASDAQ:PETS), following its fourth quarter and fiscal 2012 results.
PetMed reported $55.9 million as revenues during the fourth quarter of fiscal 2012, surpassing both the year-ago quarter and the Zacks Consensus Estimate. The company reported an EPS of 20 cents for the quarter, a penny above the year-ago quarter and ahead of the Zacks Consensus Estimate of 18 cents.
The 10% year-over-year rise in revenues during the quarter was … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards